B2BROKER's Report Is Live: 63% Brokers Launch with Integrated Stack in Just 10 Days GlobeNewswire January 07, 2026 DUBAI, The United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — B2BROKER, a global fintech solutions provider for financial institutions, unveiled its Fintech Market Report 2025. Drawing from proprietary client data, the report reveals an interesting shift […]
New York , Jan. 07, 2026 (GLOBE NEWSWIRE) — Vetted Prop Firms, a leading independent review and comparison platform for proprietary trading firms, has announced a new strategic partnership with SabioTrade, aimed at delivering exclusive crypto prop trading deals and enhanced transparency for traders worldwide. This partnership marks another step in Vetted Prop Firms' mission
Vetted Prop Firms Partners with SabioTrade to Unlock Exclusive Crypto Prop Trading Opportunities GlobeNewswire January 07, 2026 New York , Jan. 07, 2026 (GLOBE NEWSWIRE) — Vetted Prop Firms, a leading independent review and comparison platform for proprietary trading firms, has announced a new strategic partnership with SabioTrade, aimed at delivering exclusive crypto prop trading
(SWX:BSLN.SW),(Boerse Stuttgart – Freiverkehr:BSLN),(Boerse Berlin – Freiverkehr:BSLN),(Boerse Frankfurt – Freiverkehr:BSLN),(Boerse Muenchen – Freiverkehr:BSLN), Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with Prokaryotics Inc., a privately held US-based biopharmaceutical company engaged
Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections GlobeNewswire January 07, 2026 Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, today announced an agreement with
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025. San Antonio, Texas–(Newsfile Corp. – January 7, 2026) – HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (BVC: HIVECO) (the “Company” or
Singapore, Singapore–(Newsfile Corp. – January 7, 2026) – Good Tokens, the nonprofit initiative of KaJ Labs, announced continued advancements in its transparent digital infrastructure designed to support social and humanitarian use cases worldwide. Through GoodTokens.org, the initiative applies blockchain technology and artificial intelligence to build accountable, efficient systems that enhance trust, coordination, and measurable outcomes
(Paris:TE),(Euronext Amsterdam:TE), Technip Energies (PARIS:TE) has been awarded two large(1) contracts by Bharat Petroleum Corporation Limited (BPCL) for key projects at its Bina refinery in Madhya Pradesh and Mumbai refinery in Maharashtra, India. The first contract covers Engineering, Procurement, Construction and Commissioning (EPCC) for new polypropylene and Butene-1 units at the Bina refinery in Madhya
Technip Energies awarded two large contracts by BPCL for new units at Bina and Mumbai refineries in India GlobeNewswire January 07, 2026 Technip Energies (PARIS:TE) has been awarded two large(1) contracts by Bharat Petroleum Corporation Limited (BPCL) for key projects at its Bina refinery in Madhya Pradesh and Mumbai refinery in Maharashtra, India. The first
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM – NTX-253 for Schizophrenia GlobeNewswire January 07, 2026 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 7, 2026 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric